drugset / Trial / NCT04017208
A Study to Assess ASP2713 in Healthy Subjects
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to evaluate safety and tolerability of ASP2713 in healthy participants. The study will also evaluate the pharmacokinetics and pharmacodynamics of ASP2713.
Timeline
- Start
- 2019-07
- Primary completion
- 2020-08
- Completion
- 2020-08
Outcome
Outcome not reported
Stopped (Business): “A business decision was made to not initiate this study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ASP2713 | Unknown | — | Intravenous |
Indications
No indication recorded.